Arun Swaminathan's most recent trade in Coya Therapeutics Inc was a trade of 293,983 Stock Option (right to buy) done . Disclosure was reported to the exchange on Jan. 22, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Coya Therapeutics Inc | Arun Swaminathan | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jan 2026 | 293,983 | 293,983 | - | - | Stock Option (right to buy) | |
| Coya Therapeutics Inc | Arun Swaminathan | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jan 2025 | 240,964 | 240,964 | - | - | Stock Option (right to buy) | |
| Coya Therapeutics Inc | Arun Swaminathan | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 7.36 per share. | 13 Nov 2024 | 5,000 | 10,000 | - | 7.4 | 36,797 | Common Stock, par value $0.0001 per share |
| Coya Therapeutics Inc | Arun Swaminathan | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 7.34 per share. | 11 Nov 2024 | 5,000 | 5,000 | - | 7.3 | 36,689 | Common Stock, par value $0.0001 per share |